Agence France Presse (03.30.12) - Monday, April 02, 2012
Under an arrangement announced Friday, French drugmaker Sanofi
will partner with India's Hetero to manufacture low-cost
antiretrovirals in South Africa. The move represents progress
toward South Africa's goal of buying 80 percent of its ARVs
from local sources, said Sanofi CEO Christopher Viehbacher.
"There is a continuous supply shortage for critical medicines
for HIV/AIDS. Only 50 percent of patients are able to receive
treatment, and there is a real need for more locally
manufactured and supplied affordable ARVs." To accommodate
increased demand, Sanofi recently upgraded its factory north
of Pretoria.